Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

iHuman (IH) Shares Outstanding (Weighted Average) (2020 - 2024)

Historic Shares Outstanding (Weighted Average) for iHuman (IH) over the last 5 years, with Q4 2024 value amounting to $36.5 million.

  • iHuman's Shares Outstanding (Weighted Average) fell 54.22% to $36.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $36.5 million, marking a year-over-year decrease of 54.22%. This contributed to the annual value of $36.5 million for FY2024, which is 238.02% down from last year.
  • According to the latest figures from Q4 2024, iHuman's Shares Outstanding (Weighted Average) is $36.5 million, which was down 54.22% from $36.7 million recorded in Q4 2023.
  • In the past 5 years, iHuman's Shares Outstanding (Weighted Average) registered a high of $41.7 million during Q4 2021, and its lowest value of $34.2 million during Q4 2020.
  • Over the past 5 years, iHuman's median Shares Outstanding (Weighted Average) value was $36.7 million (recorded in 2023), while the average stood at $37.3 million.
  • Per our database at Business Quant, iHuman's Shares Outstanding (Weighted Average) skyrocketed by 2210.83% in 2021 and then plummeted by 1013.78% in 2022.
  • iHuman's Shares Outstanding (Weighted Average) (Quarter) stood at $34.2 million in 2020, then rose by 22.11% to $41.7 million in 2021, then decreased by 10.14% to $37.5 million in 2022, then decreased by 2.14% to $36.7 million in 2023, then fell by 0.54% to $36.5 million in 2024.
  • Its Shares Outstanding (Weighted Average) was $36.5 million in Q4 2024, compared to $36.7 million in Q4 2023 and $37.5 million in Q4 2022.